Elicio Therapeutics, Inc. (ELTX)

Elicio Therapeutics Statistics

Total Valuation

ELTX has a market cap or net worth of $230.50 million. The enterprise value is $229.89 million.

Market Cap	230.50M
Enterprise Value	229.89M

Important Dates

The last earnings date was Monday, May 11, 2026, after market close.

Earnings Date	May 11, 2026
Ex-Dividend Date	n/a

Share Statistics

ELTX has 18.40 million shares outstanding. The number of shares has increased by 29.18% in one year.

Current Share Class	18.40M
Shares Outstanding	18.40M
Shares Change (YoY)	+29.18%
Shares Change (QoQ)	+17.44%
Owned by Insiders (%)	30.90%
Owned by Institutions (%)	16.31%
Float	12.71M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.24

Current Ratio	2.24
Quick Ratio	2.07
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-27.55

Financial Efficiency

Return on equity (ROE) is -1,076.34% and return on invested capital (ROIC) is -170.21%.

Return on Equity (ROE)	-1,076.34%
Return on Assets (ROA)	-92.41%
Return on Invested Capital (ROIC)	-170.21%
Return on Capital Employed (ROCE)	-243.08%
Weighted Average Cost of Capital (WACC)	11.87%
Revenue Per Employee	n/a
Profits Per Employee	-$1.22M
Employee Count	33
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +61.68% in the last 52 weeks. The beta is 1.44, so ELTX's price volatility has been higher than the market average.

Beta (5Y)	1.44
52-Week Price Change	+61.68%
50-Day Moving Average	10.89
200-Day Moving Average	9.98
Relative Strength Index (RSI)	61.86
Average Volume (20 Days)	139,327

Short Selling Information

The latest short interest is 1.74 million, so 9.46% of the outstanding shares have been sold short.

Short Interest	1.74M
Short Previous Month	1.66M
Short % of Shares Out	9.46%
Short % of Float	13.69%
Short Ratio (days to cover)	12.31

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-37.58M
Pretax Income	-40.19M
Net Income	-40.19M
EBITDA	-37.38M
EBIT	-37.58M
Earnings Per Share (EPS)	-$2.42

Balance Sheet

The company has $14.95 million in cash and $14.34 million in debt, with a net cash position of $608,000 or $0.03 per share.

Cash & Cash Equivalents	14.95M
Total Debt	14.34M
Net Cash	608,000
Net Cash Per Share	$0.03
Equity (Book Value)	-1.44M
Book Value Per Share	-0.08
Working Capital	8.97M

Cash Flow

In the last 12 months, operating cash flow was -$38.48 million and capital expenditures -$16,000, giving a free cash flow of -$38.49 million.

Operating Cash Flow	-38.48M
Capital Expenditures	-16,000
Depreciation & Amortization	197,000
Net Borrowing	9.87M
Free Cash Flow	-38.49M
FCF Per Share	-$2.09

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ELTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-29.18%
Shareholder Yield	-29.18%
Earnings Yield	-17.43%
FCF Yield	-16.70%

Analyst Forecast

The average price target for ELTX is $18.00, which is 43.66% higher than the current price. The consensus rating is "Buy".

Price Target	$18.00
Price Target Difference	43.66%
Analyst Consensus	Buy
Analyst Count	4
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2